AnalystsDebanjana ChatterjeeDebanjana Chatterjee's Stock Forecasts
AnalystsDebanjana Chatterjee
Sectors:
Industries:
Analyst Ranking
Bottom 19%
#4003 out of 4871 analysts
Average Return
-12.02%
Win Rate
43%3 out of 7
Risk vs Reward
Poor
Good
Debanjana Chatterjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tvardi Therapeutics IncTVRD | +27.16% | $21.02 | $26.73 | 2025-04-27 - 2025-05-02 | Strong Buy |
Kalvista Pharmaceuticals IncKALV | +12.26% | $12.07 | $13.55 | 2025-03-25 - 2025-05-02 | Strong Buy |
Kalvista Pharmaceuticals IncKALV | +9.81% | $12.34 | $13.55 | 2024-09-26 - 2025-05-02 | Strong Buy |
Debanjana Chatterjee Analyst Color
Get additional color on Debanjana Chatterjee's coverage of popular stocks
Debanjana Chatterjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $39.00 | +45.90% | Initiates Coverage On | 6 days ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $30.00 | +121.40% | Maintains | a month ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $23.00 | +460.98% | Initiates Coverage On | 2 months ago |
Sagimet Biosciences IncSGMT | 1 | Strong Buy | $42.00 | +996.61% | Initiates Coverage On | 3 months ago |
Pharvaris NvPHVS | 1 | Strong Buy | $46.00 | +150.41% | Initiates Coverage On | 7 months ago |
Intellia Therapeutics IncNTLA | 1 | Strong Buy | $41.00 | +363.80% | Initiates Coverage On | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.